All In Biotech

Drug Trial Radar · NCT05359055

Drug-drug Interaction Study of SPH3127

An Open-label, Fixed Sequence Study to Evaluate the Effects of Multi-dose of Itraconazole or Rifampin on the Pharmacokinetic Profiles of Single Dose of SPH3127 in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Dec 13, 2021

Primary completion

Jan 21, 2022

Study completion Jan 21, 2022

Sponsor

Sponsor type
Industry
First posted
May 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A single center, open-label, fixed sequence Phase 1, drug-drug interaction (DDI) study in male healthy subjects.

Conditions

  • Drug Drug Interaction

Interventions

  • SPH3127 tabletDrug

    100mg once daily on Day 1 and Day 8

  • ItraconazoleDrug

    200mg once daily from Day 3 to Day10.

  • SPH3127 tabletDrug

    200mg once daily on Day 1 and Day 12.

  • RifampinDrug

    600mg once daily from Day 3 to Day13.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum serum concentration (Cmax) of SPH3127Time frame: Up to 14 days
  2. Area under the serum concentration-time curve (AUC) of the Dosing Interval (0-Last) of SPH3127Time frame: Up to 14 days
  3. Area under the serum concentration-time curve (AUC) of the Dosing Interval (0-infinity) of SPH3127Time frame: Up to 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • West China Second University Hospital, Sichuan University

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.